4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-008130
EVP, Chief Medical Officer sold 1,704 shares at $9.86 ($16,805)
From the SEC's structured data for this filing
Trades in this filing
Shah Jatin · EVP, Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-07 | Sale : show line 1 in the form | −1,704 | $9.86 | $16,805 | 130,756 | D |
| Open-market sales · 1,704 sh · avg $9.86 · $16,805 | ||||||
Loading xslF345X03/doc4.xml…